Kiora Pharmaceuticals Inc (KPRX)

NASDAQ
0.162
-0.019(-10.71%)
After Hours
0.162
-0.001(-0.613%)
- Real-time Data
  • Volume:
    34,574,055
  • Day's Range:
    0.160 - 0.203
  • 52 wk Range:
    0.140 - 2.340
Unusual trading volume
1 / 2

KPRX Overview

Prev. Close
0.182
Day's Range
0.16-0.203
Revenue
-
Open
0.199
52 wk Range
0.14-2.34
EPS
-1.38
Volume
34,574,055
Market Cap
5.97M
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
2,020,989
P/E Ratio
-0.177
Beta
0.81
1-Year Change
-90.03%
Shares Outstanding
36,763,123
Next Earnings Date
Aug 15, 2022
What is your sentiment on Kiora Pharmaceuticals?
or
Market is currently closed. Voting is open during market hours.

Kiora Pharmaceuticals Inc News

Welcome to Your News Upgrade

Be the First to Know and Act on Market Moving News.

Welcome to Your News Upgrade

Kiora Pharmaceuticals Inc Analysis

Kiora Pharmaceuticals Inc Company Profile

Kiora Pharmaceuticals Inc Company Profile

Employees
14

Kiora Pharmaceuticals, Inc., a clinical-stage specialty pharmaceutical company, develops and commercializes therapies for the treatment of ophthalmic diseases in the United States. Its lead product is KIO-301, a potential vision-restoring small molecule, which is in Phase 1 clinical trial that acts as a photoswitch to restore vision in patients with inherited and age-related degenerative retinal diseases. The company is also developing KIO-101, an eye drop that is in Phase 2 clinical trial for the treatment of ocular presentation of rheumatoid arthritis, as well as for treating non-infectious posterior uveitis; and KIO-201, an eye drop, which is in Phase 3 clinical trial for treating patients undergoing PRK surgery for corneal wound repair after refractive surgery. The company was formerly known as Eyegate Pharmaceuticals, Inc. and changed its name to Kiora Pharmaceuticals, Inc. in November 2021. Kiora Pharmaceuticals, Inc. was incorporated in 1998 and is headquartered in Salt Lake City, Utah.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesNeutralSellSellSellStrong Sell
Technical IndicatorsStrong SellStrong SellSellSellStrong Sell
SummarySellStrong SellSellSellStrong Sell
  • Added at $ 0.68 scooped up some swing shares here low float bio
    0
    • hello
      0
      • What happening?
        3
        • seems like it will go up, Insider just purchased more then 150k share: https://www.extrach.com/stock/EYEG
          1
          • Soon $10
            3
            • Perfect time to opt out and all shares are on hold :(
              0
              • Rises on positive study data for eye gel
                0
                • Why is losing to much?
                  0